| http://www.w3.org/ns/prov#value | - Frank H. Laukien, Ph.D., President and CEO of Bruker BioSciences, commented: The new Proteomics RIMS is a joint solution resulting from synergistic research and development efforts after the merger of Bruker Daltonics and Bruker AXS in July 2003.
|
